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r D. Craig Miller (Stanford, Calif). Thank you, Dr Borger. That
as a nice presentation. I don’t want anyone in this room to run home
nd try this, however. Despite how great it looks on the surface, it
ooks too good to be true and probably is too good to be true.
Let me reframe the controversy for the audience. Robert Levine’s
GH group has shown in acute and chronic sheep models of IMR
hat if you cut the second-order chords there is more leaflet area for
oaptation and the valve is more competent. My concern has always
een what cost do you pay in terms of ventricular systolic function
hen you cut the second-order chordae? Indeed, it is ironic that the
enior author on this paper is the very one and same Tirone E. David
ho first convincingly demonstrated in a canine experimental prep-
ration 23 years ago that cutting the chordae tendineae was bad for left
entricular systolic function. Further, these are sick ventricles. To
araphrase the Gorman brothers: IMR is not a valvular disease, it’s a
entricular disease, and these are sick ventricles crying out for help. If
e impair their LV contractile performance more, we actually may be
arming patients even if there is less postoperative recurrent IMR.
Congratulations for proving in the first sizable clinical series that
utting second-order chordae is feasible and safe with no apparent
arly side effects. I remain unconvinced, however, that the putative
echanism responsible for less recurrent MR was actually due to c
490 The Journal of Thoracic and Cardiovascular Surgery ● Junhat you did. I also am skeptical that you actually did not impair left
entricular systolic function by cutting the chords.
Why am I unconvinced? First, you do not have the proper con-
urrent control group -- similar patients with IMR undergoing CABG
lone -- but none of us do. A prospective controlled trial where
ne-half of your IMR patients was randomized to chordal division
ould be ideal, but we do not live in a utopia. More practically
peaking, you have not analyzed all the intra-operative and postoper-
tive echo data available to you, which is where you have let us and
ourselves down.
You showed us intraoperative TEE data for just the first 20
atients in each group. Why didn’t you analyze the echo data for all
2 patients? Further, you focused exclusively on type III-b leaflet
otion (restricted systolic leaflet closure). IMR is often a combination
f septal-lateral (S-L) annular dilatation (type I or normal leaflet
otion with IMLC) and type III-b leaflet motion. You didn’t even tell
s what kind of moderate IMR leaks you were treating. Were these
ccentric complex MR jets (type III-B) or central straight back jets
type I), or both mechanisms, as we frequently see?
As an editorial comment, I think you have used the completely
rong type of ring for these IMR patients. A Cosgrove band is great
or prolapse, but I think most of us now believe IMR is best treated by
complete, very rigid ring which by design disproportionately down-
izes the AP or S-L annular axis.
Let’s get back to the echo information. I was disappointed that you
resented quantitative intraoperative TEE data for only 20 patients in
ach group. Indeed, you could not even prove statistically that cutting
he second-order chordae reduced tenting area or height compared to
he more conventional ring only group based on these numbers.
aybe analysis of larger numbers of patients would have allowed you
o substantiate your the conclusion and prove that the reduced inci-
ence of postoperative IMR was due to less apical tethering, a direct
ffect of cutting the second-order chordae. Further, for the 2 year
ostoperative transthoracic echocardiograms you don’t give us any
nformation aside from how many patients had moderate or worse
ecurrent IMR. What about mitral S-L annular dimension, tenting
rea, tenting height and all the LV dimensions and geometry for all
urvivors in both groups, and specifically for those with recurrent
MR? Was there more salutary reverse LV remodeling over time in
he chordal-cutting group? I applaud you for demonstrating a major
eduction in postoperative residual/recurrent IMR in the chordal di-
ision group, but we need to know why this happened on a mecha-
istic basis. I’m just not sure that cutting the second-order chordae
ruly explains these favorable results. Many things were changing
ver time, the patient cohorts were dissimilar, and these two technical
pproaches were applied sequentially and not concurrently.
Concerning LV systolic function, as you and I have discussed
arlier, the audience should be circumspect in that you did perform
ny rest and exercise echo or radionuclear stress testing to assess LV
ontractile reserve. Just looking at changes in resting echo EF is not
ery persuasive.
In the event-free survival curves which clearly favored the chord-
l-cutting technique, perhaps you may have been a little bit mislead-
ng. You excluded recurrent IMR as part of this composite clinical
nd-point. There was one patient in the chordal-cutting group who
ad severe recurrent MR but was deemed inoperable and therefore not
eoperated on. This important complication is missing from these
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CDecurrent MR, I think you have enough adverse events in a large
nough population that these data could have been subjected to what
he Toronto group has regularly done in their clinical research efforts,
hat is, test your hypothesis using a rigorous multivariable Cox model
ith bootstrapping, ideally including propensity score analysis (if you
ad enough patients to unbalance the numbers in order to balance the
isk of adverse outcome). Some of the independent variables to be
ntered would include all the clinical descriptors, operative year,
urgeon identifier, chordal-cutting technique or not, annuloplasty band
ize, and interval between last MI to operation. This type of compre-
ensive statistical approach is the only robust way to demonstrate
rom your retrospective data whether or not dividing the second-order
hords is more effective than your conventional repair method. Let us
ot forget that patient selection biases and surgeon bias are ubiqui-
ous!
I thank you, Mike, and your colleagues for this important work
nd demonstrating it is safe and feasible to cut the second-order
hordae during mitral valve repair for patients with IMR. I only wish
ll the data had been analyzed and the statistical approach had been
ore rigorous.
Dr. Borger: Thank you, Dr. Miller. Trying to defend a paper on
schemic mitral regurgitation to you is a little bit like trying to defend
paper on the theory of relativity to Einstein. But I will try.
First of all, your comments about how our philosophy has changed
rom preaching that we have to retain chords to now saying that we
an sacrifice them, there is a bit of a subtle difference there. The
riginal studies that said that we should retain continuity between the
nnulus and the papillary muscles when you replace the mitral valve,
hey did not make a distinction between primary and secondary
hords. What we are proposing now is cutting the secondary chords
nly. The primary chords remain intact and therefore there is conti-
uity of the papillary muscle-annular mechanism.
Why did we not obtain detailed intraoperative echo data on all of
he patients? My only response is that these measurements are ex-
remely time-consuming to perform. All of these measurements were
btained during off-line analysis of two different cardiac cycles,
hich takes a lot of time. In addition, we felt that the more important
linical outcome was recurrent mitral regurgitation on postoperative
ransthoracic echo rather than intraoperative TEE measurments. But
ou’ve raised a valid point and I will have to go back and queue up
hose tapes and get some more data on the remaining patients.
Regarding your question on the mechanism of the mitral regurgi-
ation, it was a typical ischemic MR leak with a combined eccentric
et and central component in the majority of patients. It is not our
bservation that ischemic MR is due mostly to annular dilatation. We
elieve that annular dilatation plays a relatively minor role in ischemic
R. When you look at our data, the average mitral annulus diameter
n both groups was only 3.4 cm, which is at the upper end of normal.
he data on the type of regurgitant jet is currently missing from the
aper, but I do have it and I will insert it.
It has been our institutional philosophy for many years that we use
partial incomplete flexible ring for ischemic MR. I am very familiar
ith the literature for ischemic mitral regurgitation, I know there are
lot of proponents of a complete rigid ring. However, I do not believe
t has been conclusively shown that a complete rigid ring is absolutely
equired. I think that it is still in the stage of equipoise, and hopefully
ver time somebody will be able to definitively determine the optimal a
The Journal of Thoracicing type. For now we are using partial incomplete rings, but a couple
f years from now we may be switching to a complete rigid ring. .
As far as left ventricular function goes, we used postoperative
ransthoracic echocardiography and this is probably not the best
ethod. Radionuclide angiography is probably a better method. How-
ver, these tests are not part of our standard postoperative clinical
ollow-up evaluation. Regardless, we feel there is a lot of evidence
uggesting that we did not adversely affected left ventricular function.
espite the chordal-cutting group having a 10% lower ejection frac-
ion, and that was an absolute 10% difference and not a relative 10%,
hese patients had no increase rate of inotrope usage, low cardiac
utput syndrome, and or mortality when compared to the undersized
nnuloplasty group. So we feel comfortable with this operation and
e do not think that it results in any obvious decrement in left
entricular function.
And then finally to address your point about our definition of
vent-free survival. We used a definition based on the currently
ccepted norms for valve surgery reporting, and those norms usually
o not include recurrent MR without reoperation. Certainly we can
dd recurrent MR, to the event-free survival curves. But thisshould
esult in an even more favorable picture of the chordal-cutting group,
ecause there were only two patients in the chordal-cutting group that
eveloped severe mitral regurgitation versus five in the undersized
nnuloplasty group. It is true that we did not reoperate on the two
hordal-cutting patients who developed recurrent MR because they
ere very sick. However, four of the five undersized annuloplasty
atients who developed recurrent MR underwent mitral valve replace-
ent.
Dr. C. Duran (Missoula, MT):
One, we have to congratulate the authors for reporting on the only
argest series with this intriguing very simple and, in my opinion,
angerous operation. I was also surprised, like Dr. Miller, that the
enter that has defended so clearly and as pioneers of this continuity
etween the papillary muscle and the annulus, now you recommend
utting the basal chords. You say they are different from the marginal
hords. They certainly are very different in terms that they are four
imes the thickness of the marginal ones and they sustain stress during
he whole cardiac cycle; they are taut during the whole cardiac cycle.
o those very impressive chords when you look from the ventricle, to
ust cut them happily and hope that nothing happens I think is a bit
remature.
We did repeat the studies, following closely the studies of the
tanford group, and in our case we cut the two medial anterior basal
hords, that is, from both halves of the anterior leaflet, and the results
mmediately, those were acute experiments, there was a drop in stroke
olume, dP/dt, increasing length between the apex and the annulus,
nd a reduction in the aortomitral angle. So they were all negative
ositions.
So my question is, why the difference, why your results are very
ood and the animal ones are very bad? Secondly, is that because in
he animals we didn’t do an annuloplasty and maybe the annuloplasty
rotects cutting those chords, or is it that we were cutting different
hords than you were? And certainly from your presentation I get the
dea that you cut the one from the A2 and commissure and the
osterior leaflet at the level of B3. I don’t know which, what expla-
ation.
But before finishing, just a warning to people. The danger is it is
simple operation, but they just walk home and they say I am going
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CDo have a series of this new technique, and I think it would be
remature. I think it is good for you to continue and to report what the
ong-term results are.
Thank you very much.
Dr. Borger: Thank you, Dr. Duran. I can see I am not gaining any
riends with this operation. I want to stress one point. We are not
rying to say that the chordal-cutting procedure is a panacea for
schemic mitral regurgitation. We have not found the cure for isch-
mic mitral regurgitation, by any means. I agree wholeheartedly with
r. Miller and Dr. Gorman that this is a very vexing clinical problem
nd we don’t have the answers yet, and surgery may not even be the
est option for many of these patients. However, often you have
atients that are hospitalized with congestive heart failure and surgery
s the only potential life raft that they have.
Regarding the differences between our observations and the del-492 The Journal of Thoracic and Cardiovascular Surgery ● Junmportant to note that the animal models involve acute ischemic
njury to normal ventricles. They are not chronic long-term ischemic
entricles like we see in patients. I believe that we should repeat the
nimal model work using hearts that have been ischemic for at least
ight weeks before we definitively state that there are deleterious
ffects for this operation. It is also important to note that we have been
ividing secondary chords during mitral valve repair for myxomatous
isease for approximately 25 years, during the sliding annuloplasty
rocedure, without any obvious detrimental effects on left ventricular
unction.
And once again, I have to stress that we are not saying that we
ave found a cure for ischemic MR. We simply feel we have found
more effective method of decreasing the amount of residual and
ecurrent mitral regurgitation than the undersized annuloplasty pro-
edure. As we continue to follow our patients, we hope to have someterious effects of cutting secondary chords in animal models, it is more answers for you over the next few years.
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